Intercept Pharmaceuticals Inc EBITDA margin
Cos'è EBITDA margin di Intercept Pharmaceuticals Inc?
EBITDA margin di Intercept Pharmaceuticals Inc è -29.95%
Qual è la definizione di EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin di aziende nel Health Care settore su NASDAQ rispetto a Intercept Pharmaceuticals Inc
Cosa fa Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Aziende con ebitda margin simili a Intercept Pharmaceuticals Inc
- Starcom Plc ha EBITDA margin di -30.13%
- Aban Offshore ha EBITDA margin di -30.08%
- Bever NV ha EBITDA margin di -30.07%
- East 33 Ltd ha EBITDA margin di -30.02%
- Symphony Environmental Technologies Plc ha EBITDA margin di -30.00%
- InnoCare Pharma ha EBITDA margin di -29.99%
- Intercept Pharmaceuticals Inc ha EBITDA margin di -29.95%
- Jimu ha EBITDA margin di -29.92%
- Zip Co ha EBITDA margin di -29.92%
- BlackRock Muni Fund II Inc ha EBITDA margin di -29.91%
- McEwen Mining ha EBITDA margin di -29.77%
- K2 Asset Management Ltd ha EBITDA margin di -29.76%
- Greenrose Acquisition ha EBITDA margin di -29.72%